PriceTargets.com logo

Align Technology - ALGN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $175.45
  • Forecasted Upside: 11.87%
  • Number of Analysts: 16
  • Breakdown:
  • 2 Sell Ratings
  • 7 Hold Ratings
  • 6 Buy Ratings
  • 1 Strong Buy Ratings
$156.84 As of 12/4/2025 05:00 PM ET
▲ +1.84 (1.19%)

This chart shows the closing price for ALGN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Align Technology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALGN

Analyst Price Target is $175.45
▲ +11.87% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for Align Technology in the last 3 months. The average price target is $175.45, with a high forecast of $206.00 and a low forecast of $150.00. The average price target represents a 11.87% upside from the last price of $156.84.

This chart shows the closing price for ALGN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 16 contributing investment analysts is to hold stock in Align Technology. This rating has held steady since October 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
12/9/2024
  • 1 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
3/9/2025
  • 1 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 2 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 2 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/25/2025Evercore ISILower TargetOutperform ➝ Outperform$220.00 ➝ $170.00
10/31/2025HSBCBoost Target$140.00 ➝ $150.00
10/30/2025Stifel NicolausSet Target$200.00
10/30/2025Evercore ISIBoost TargetOutperform ➝ Outperform$160.00 ➝ $170.00
10/30/2025Needham & Company LLCReiterated RatingHold ➝ Hold
10/30/2025Leerink PartnersBoost Target$172.00 ➝ $189.00
10/30/2025Jefferies Financial GroupBoost Target$140.00 ➝ $155.00
10/30/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$142.00 ➝ $154.00
10/30/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$199.00 ➝ $181.00
10/30/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$190.00 ➝ $200.00
10/23/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$190.00
10/21/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$154.00 ➝ $142.00
10/16/2025UBS GroupLower TargetNeutral ➝ Neutral$160.00 ➝ $155.00
10/14/2025Leerink PartnersLower TargetOutperform ➝ Outperform$188.00 ➝ $172.00
10/13/2025MizuhoLower TargetOutperform ➝ Outperform$210.00 ➝ $170.00
10/10/2025Jefferies Financial GroupReiterated RatingBuy ➝ Hold$215.00 ➝ $140.00
10/8/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
10/8/2025Evercore ISILower TargetOutperform ➝ Outperform$170.00 ➝ $160.00
9/30/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/1/2025Zacks ResearchDowngradeHold ➝ Strong Sell
7/31/2025MizuhoSet Target$210.00
7/31/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$246.00 ➝ $199.00
7/31/2025Stifel NicolausLower TargetBuy ➝ Buy$275.00 ➝ $200.00
7/31/2025Piper SandlerLower TargetOverweight ➝ Overweight$250.00 ➝ $190.00
7/31/2025Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$249.00 ➝ $154.00
7/9/2025Evercore ISIBoost TargetOutperform ➝ Outperform$200.00 ➝ $220.00
5/1/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$255.00 ➝ $246.00
5/1/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$235.00 ➝ $250.00
5/1/2025Evercore ISIBoost TargetOutperform ➝ Outperform$165.00 ➝ $200.00
5/1/2025Needham & Company LLCReiterated RatingHold ➝ Hold
4/29/2025MizuhoLower TargetOutperform ➝ Outperform$250.00 ➝ $245.00
4/25/2025Hsbc Global ResDowngradeStrong-Buy ➝ Hold
4/25/2025HSBCDowngradeBuy ➝ Hold$290.00 ➝ $170.00
4/24/2025UBS GroupLower TargetNeutral ➝ Neutral$240.00 ➝ $215.00
3/25/2025MizuhoLower TargetOutperform ➝ Outperform$295.00 ➝ $250.00
3/18/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$270.00 ➝ $235.00
2/14/2025Wells Fargo & CompanyInitiated CoverageOverweight$255.00
2/6/2025Evercore ISIBoost TargetOutperform ➝ Outperform$240.00 ➝ $260.00
2/6/2025Morgan StanleyLower TargetOverweight ➝ Overweight$280.00 ➝ $272.00
2/6/2025Needham & Company LLCReiterated RatingHold ➝ Hold
2/6/2025Piper SandlerLower TargetOverweight ➝ Overweight$275.00 ➝ $270.00
1/23/2025Jefferies Financial GroupLower TargetBuy ➝ Buy$285.00 ➝ $260.00
1/6/2025Leerink PartnrsUpgradeHold ➝ Strong-Buy
1/6/2025Leerink PartnersUpgradeMarket Perform ➝ Outperform$235.00 ➝ $280.00
12/13/2024Bank of AmericaBoost TargetUnderperform ➝ Underperform$200.00 ➝ $206.00
12/4/2024MizuhoInitiated CoverageOutperform$295.00
11/4/2024Needham & Company LLCReiterated RatingHold
10/24/2024Morgan StanleyLower TargetOverweight ➝ Overweight$310.00 ➝ $280.00
10/24/2024Stifel NicolausLower TargetBuy ➝ Buy$285.00 ➝ $275.00
10/24/2024Evercore ISILower TargetOutperform ➝ Outperform$270.00 ➝ $250.00
10/24/2024Piper SandlerLower TargetOverweight ➝ Overweight$285.00 ➝ $275.00
10/24/2024Needham & Company LLCReiterated RatingHold
10/24/2024Robert W. BairdLower TargetOutperform ➝ Outperform$325.00 ➝ $276.00
10/17/2024Piper SandlerLower TargetOverweight ➝ Overweight$315.00 ➝ $285.00
10/11/2024Stifel NicolausLower TargetBuy ➝ Buy$350.00 ➝ $285.00
10/10/2024Needham & Company LLCInitiated CoverageHold
10/8/2024Evercore ISILower TargetOutperform ➝ Outperform$280.00 ➝ $270.00
9/13/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$315.00 ➝ $315.00
7/25/2024Morgan StanleyLower TargetOverweight ➝ Overweight$328.00 ➝ $310.00
7/25/2024Stifel NicolausLower TargetBuy ➝ Buy$400.00 ➝ $350.00
7/25/2024Piper SandlerLower TargetOverweight ➝ Overweight$330.00 ➝ $315.00
7/22/2024Robert W. BairdLower TargetOutperform ➝ Outperform$370.00 ➝ $325.00
7/10/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$330.00 ➝ $330.00
6/21/2024Piper SandlerLower TargetOverweight ➝ Overweight$375.00 ➝ $330.00
6/10/2024Evercore ISILower TargetOutperform ➝ Outperform$370.00 ➝ $300.00
6/4/2024OTR GlobalReiterated RatingPositive ➝ Mixed
4/25/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$344.00 ➝ $360.00
4/25/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$355.00 ➝ $375.00
4/25/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$333.00 ➝ $370.00
4/18/2024Stifel NicolausBoost TargetBuy ➝ Buy$350.00 ➝ $400.00
4/15/2024UBS GroupBoost TargetNeutral ➝ Neutral$280.00 ➝ $320.00
3/15/2024Stifel NicolausBoost TargetBuy ➝ Buy$340.00 ➝ $350.00
3/14/2024Piper SandlerBoost TargetOverweight ➝ Overweight$335.00 ➝ $355.00
2/26/2024Leerink PartnrsReiterated RatingMarket Perform
2/26/2024Leerink PartnersInitiated CoverageMarket Perform$310.00
2/2/2024The Goldman Sachs GroupBoost TargetSell ➝ Sell$197.00 ➝ $225.00
2/1/2024Piper SandlerBoost TargetOverweight ➝ Overweight$290.00 ➝ $335.00
1/30/2024UBS GroupBoost TargetNeutral ➝ Neutral$200.00 ➝ $260.00
12/11/2023The Goldman Sachs GroupDowngradeNeutral ➝ Sell$197.00
10/27/2023UBS GroupDowngradeBuy ➝ Neutral$200.00
10/26/2023Piper SandlerLower TargetOverweight ➝ Overweight$370.00 ➝ $290.00
10/26/2023Morgan StanleyLower TargetOverweight ➝ Overweight$415.00 ➝ $378.00
10/24/2023Stifel NicolausLower TargetBuy ➝ Buy$430.00 ➝ $390.00
10/11/2023Evercore ISILower Target$400.00 ➝ $320.00
9/14/2023OTR GlobalUpgradeMixed ➝ Positive
8/30/2023HSBCInitiated CoverageBuy$450.00
8/24/2023Stifel NicolausBoost TargetBuy ➝ Buy$390.00 ➝ $430.00
7/27/2023Morgan StanleyBoost TargetOverweight$383.00 ➝ $415.00
7/27/2023Jefferies Financial GroupBoost Target$367.00 ➝ $400.00
7/27/2023Piper SandlerBoost Target$370.00 ➝ $415.00
7/27/2023Robert W. BairdBoost Target$385.00 ➝ $406.00
6/16/2023OTR GlobalDowngradePositive
4/27/2023VNET GroupReiterated RatingMaintains
4/27/2023Bank of AmericaBoost Target$190.00 ➝ $225.00
4/27/2023Piper SandlerBoost Target$360.00 ➝ $370.00
4/19/2023Morgan StanleyBoost TargetOverweight$314.00 ➝ $383.00
4/18/2023Stifel NicolausBoost TargetBuy$375.00 ➝ $390.00
3/31/2023OTR GlobalUpgradeMixed ➝ Positive
3/23/2023CICC ResearchInitiated CoverageMarket Perform
2/2/2023Evercore ISIBoost TargetOutperform$230.00 ➝ $375.00
2/2/2023Stifel NicolausBoost TargetBuy$265.00 ➝ $375.00
2/2/2023The Goldman Sachs GroupUpgradeSell ➝ Neutral$165.00 ➝ $307.00
2/2/2023Robert W. BairdBoost TargetOutperform$260.00 ➝ $335.00
2/2/2023Piper SandlerBoost TargetOverweight$255.00 ➝ $360.00
1/11/2023Piper SandlerBoost TargetOverweight$230.00 ➝ $255.00
10/27/2022The Goldman Sachs GroupLower TargetSell$250.00 ➝ $165.00
10/27/2022Morgan StanleyLower TargetOverweight$402.00 ➝ $314.00
10/27/2022Stifel NicolausLower Target$325.00 ➝ $265.00
10/27/2022Robert W. BairdLower Target$310.00 ➝ $260.00
10/27/2022Piper SandlerLower Target$300.00 ➝ $230.00
10/13/2022Piper SandlerLower TargetOverweight$340.00 ➝ $300.00
10/12/2022Stifel NicolausLower TargetBuy ➝ Buy$375.00 ➝ $325.00
9/9/2022Piper SandlerLower TargetOverweight$370.00 ➝ $340.00
7/29/2022UBS GroupLower TargetBuy$380.00 ➝ $370.00
7/28/2022StephensLower TargetOverweight$500.00 ➝ $375.00
7/28/2022Morgan StanleyLower TargetOverweight$438.00 ➝ $402.00
7/28/2022Evercore ISILower Target$310.00 ➝ $285.00
7/28/2022Robert W. BairdLower TargetOutperform$450.00 ➝ $410.00
7/28/2022The Goldman Sachs GroupDowngradeBuy ➝ Sell$380.00 ➝ $250.00
7/22/2022Piper SandlerLower TargetOverweight$440.00 ➝ $370.00
7/20/2022Morgan StanleyLower TargetOverweight$479.00 ➝ $438.00
7/18/2022UBS GroupLower Target$410.00 ➝ $380.00
7/14/2022Stifel NicolausLower TargetBuy$425.00 ➝ $375.00
6/15/2022Morgan StanleyLower TargetOverweight$524.00 ➝ $479.00
5/4/2022Credit Suisse GroupLower Target$722.00 ➝ $418.00
4/28/2022Stifel NicolausLower Target$575.00 ➝ $425.00
4/28/2022Morgan StanleyLower Target$575.00 ➝ $524.00
4/28/2022Robert W. BairdLower TargetOutperform$625.00 ➝ $510.00
4/28/2022Piper SandlerLower Target$600.00 ➝ $440.00
4/26/2022UBS GroupLower TargetBuy$620.00 ➝ $500.00
4/21/2022Piper SandlerLower TargetOverweight$740.00 ➝ $600.00
2/3/2022Robert W. BairdLower Target$745.00 ➝ $650.00
2/3/2022Stifel NicolausLower TargetBuy$675.00 ➝ $625.00
2/3/2022Credit Suisse GroupLower TargetOutperform$782.00 ➝ $722.00
1/31/2022UBS GroupUpgradeNeutral ➝ Buy$880.00 ➝ $620.00
1/31/2022Morgan StanleyInitiated CoverageOverweight$575.00
1/21/2022Stifel NicolausLower Target$750.00 ➝ $675.00
11/1/2021William BlairReiterated RatingOutperform
10/28/2021The Goldman Sachs GroupDowngradeBuy$810.00
10/28/2021Piper SandlerBoost TargetPositive ➝ Overweight$775.00 ➝ $825.00
7/29/2021William BlairReiterated RatingOutperform
7/29/2021Credit Suisse GroupBoost TargetOutperform ➝ Outperform$715.00 ➝ $732.00
7/29/2021Piper SandlerBoost TargetOverweight$735.00 ➝ $775.00
7/9/2021StephensUpgradeEqual Weight ➝ Overweight$600.00 ➝ $700.00
7/8/2021Exane BNP ParibasInitiated CoverageOutperform$790.00
7/8/2021BNP ParibasInitiated CoverageOutperform$790.00
4/29/2021Leerink PartnersBoost TargetPositive ➝ Outperform$690.00 ➝ $770.00
4/29/2021Credit Suisse GroupBoost TargetOutperform$693.00 ➝ $715.00
4/29/2021Stifel NicolausBoost TargetBuy$650.00 ➝ $750.00
4/29/2021Robert W. BairdBoost TargetOutperform$655.00 ➝ $745.00
4/29/2021Piper SandlerBoost TargetOverweight$700.00 ➝ $735.00
4/22/2021Berenberg BankUpgradeHold ➝ Buy$683.00
4/15/2021Leerink PartnersBoost TargetOutperform$680.00 ➝ $690.00
2/4/2021Evercore ISIBoost TargetOutperform$625.00 ➝ $680.00
2/4/2021Credit Suisse GroupBoost TargetOutperform$618.00 ➝ $630.00
2/4/2021Leerink PartnersBoost TargetOutperform$620.00 ➝ $680.00
2/4/2021BarclaysBoost TargetEqual Weight$475.00 ➝ $555.00
2/2/2021Piper SandlerBoost TargetOverweight$525.00 ➝ $610.00
1/4/2021Evercore ISIUpgradeIn-Line ➝ Outperform$625.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.14 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 27 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 48 very positive mentions
  • 40 positive mentions
  • 12 negative mentions
  • 6 very negative mentions
Mentions as of
8/6/2025
  • 58 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 4 very negative mentions
Mentions as of
9/5/2025
  • 44 very positive mentions
  • 27 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
10/5/2025
  • 40 very positive mentions
  • 34 positive mentions
  • 12 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 50 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 50 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Align Technology logo
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
Read More

Today's Range

Now: $156.84
Low: $153.17
High: $156.95

50 Day Range

MA: $136.38
Low: $125.22
High: $156.84

52 Week Range

Now: $156.84
Low: $122.00
High: $246.19

Volume

1,347,840 shs

Average Volume

1,488,909 shs

Market Capitalization

$11.25 billion

P/E Ratio

30.40

Dividend Yield

N/A

Beta

1.86

Frequently Asked Questions

What sell-side analysts currently cover shares of Align Technology?

The following equities research analysts have issued stock ratings on Align Technology in the last twelve months: Bank of America Corporation, Evercore ISI, Hsbc Global Res, HSBC Holdings plc, Jefferies Financial Group Inc., Leerink Partners, Leerink Partnrs, Mizuho, Morgan Stanley, Needham & Company LLC, Piper Sandler, Stifel Nicolaus, UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for ALGN.

What is the current price target for Align Technology?

0 Wall Street analysts have set twelve-month price targets for Align Technology in the last year. Their average twelve-month price target is $175.45, suggesting a possible upside of 11.9%. Bank of America Corporation has the highest price target set, predicting ALGN will reach $206.00 in the next twelve months. HSBC Holdings plc has the lowest price target set, forecasting a price of $150.00 for Align Technology in the next year.
View the latest price targets for ALGN.

What is the current consensus analyst rating for Align Technology?

Align Technology currently has 2 sell ratings, 7 hold ratings, 6 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ALGN, but not buy more shares or sell existing shares.
View the latest ratings for ALGN.

What other companies compete with Align Technology?

Other companies that are similar to Align Technology include DexCom, HealthEquity, Henry Schein, Medpace and Quanterix. Learn More about companies similar to Align Technology.

How do I contact Align Technology's investor relations team?

Align Technology's physical mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider's listed phone number is (602) 742-2000 and its investor relations email address is [email protected]. The official website for Align Technology is www.aligntech.com. Learn More about contacing Align Technology investor relations.